CH
Christopher Harris Wells Fargo Latest Price Targets & Analyst Ratings
# | Stock | Price | Price Target |
Upside Downside | Rating | Date | |
---|---|---|---|---|---|---|---|
1 |
1
KKR & Co
KKR
$121B
| $135.53 | $90 |
34%
downside
| Overweight | 3 years ago |
|
2 |
2
Stifel
SF
$11.5B
| $112.58 | $74 |
34%
downside
| Equal-Weight | 4 years ago |
|
3 |
3
T Rowe Price
TROW
$23.8B
| $108.16 | $215 |
99%
upside
| Overweight | 4 years ago |
|
4 |
4
Blackrock
BLK
$170B
| $1,099.15 | $890 |
19%
downside
| Overweight | 4 years ago |
|
5 |
5
CME Group
CME
$94.4B
| $261.94 | $230 |
12%
downside
| Overweight | 4 years ago |
|
6 |
6
Gartner
IT
$18.6B
| $245.91 | $187 |
24%
downside
| Equal-Weight | 4 years ago |
|
7 |
7
Raymond James Financial
RJF
$33B
| $165.50 | $80 |
52%
downside
| Overweight | 4 years ago |
|
8 |
8
Charles Schwab
SCHW
$167B
| $92.05 | $58 |
37%
downside
| Overweight | 4 years ago |
|
9 |
9
Ares Management
ARES
$38.9B
| $177.31 | $51 |
71%
downside
| Overweight | 4 years ago |
|
10 |
10
Franklin Resources
BEN
$13B
| $24.97 | $20 |
20%
downside
| Underweight | 4 years ago |
|
11 |
11
Cboe Global Markets
CBOE
$24.3B
| $232.58 | $105 |
55%
downside
| Overweight | 4 years ago |
|
12 |
12
Nasdaq
NDAQ
$53.6B
| $93.48 | $45 |
52%
downside
| Overweight | 5 years ago |
|
13 |
13
LPL Financial
LPLA
$26.6B
| $332.99 | $83 |
75%
downside
| Overweight | 5 years ago |
|
14 |
14
Interactive Brokers
IBKR
$26.8B
| $60.16 | $11 |
82%
downside
| Underweight | 5 years ago |
|
15 |
15
Hamilton Lane
HLNE
$6.41B
| $146.12 | $66 |
55%
downside
| Equal-Weight | 5 years ago |
|
16 |
16
Blackstone
BX
$133B
| $169.99 | $63 |
63%
downside
| Overweight | 5 years ago |
|
17 |
17
Apollo Global Management
APO
$75.3B
| $131.55 | $48 |
64%
downside
| Overweight | 5 years ago |
|
18 |
18
Janus Henderson
JHG
$6.91B
| $44.28 | $17 |
62%
downside
| Underweight | 5 years ago |
|
19 |
19
Intercontinental Exchange
ICE
$99.8B
| $174.27 | $101 |
42%
downside
| Overweight | 5 years ago |
|
20 |
20
Invesco
IVZ
$9.81B
| $21.99 | $7 |
68%
downside
| Underweight | 5 years ago |
|
21 |
21
Edwards Lifesciences
EW
$47.5B
| $80.94 | $71.67 |
11%
downside
| Overweight | 5 years ago |
|